Last reviewed · How we verify
NCT05050981
Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life
trial testing Hormone replacement therapy in Menopause in 74 participants. Completed in 28 February 2022.
28 February 2022
Quick facts
| Lead sponsor | Faculdade de Medicina do ABC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 74 |
| Start date | 1 March 2021 |
| Primary completion | 28 February 2022 |
| Estimated completion | 28 February 2022 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Hormone replacement therapy — full drug profile →
- Selective serotonin reuptake inhibitors — full drug profile →
Conditions studied
- Menopause — all drugs for Menopause →
Sponsor
Faculdade de Medicina do ABC — full company profile →
Who can join
Adults 45 to 65, female only, with Menopause. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cross-sectional study with postmenopausal women using hormone therapy or serotonin reuptake inhibitor to relieve climacteric symptoms or without any treatment. Participants will answer three questionnaires: FSFI (the Female Sexual Function Index), MENQOL (Menopause-specific Quality of Life) and MEEM (Mini-Mental State Examination). The results will be compared according to treatment group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05050981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hormone replacement therapy
Trials testing the same drug.
- NCT07020429 — Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency · NA · not yet recruiting
- NCT06679816 — Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors · Phase 4 · recruiting
- NCT04962386 — Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD · unknown
Other recruiting trials for Menopause
Currently open trials in the same condition.
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
- NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
- NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting
Other Faculdade de Medicina do ABC trials
Trials by the same sponsor.
- NCT05011240 — Parent-mediated Social-communication Therapy for Young Children Living in Poverty in Brazil · NA · unknown
- NCT05072756 — Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits · completed
- NCT06872385 — Profile of Brazilian Climacteric Women: the Brazilian Menopause Study · completed
- NCT04181346 — Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting · Phase 2 · unknown
- NCT03607045 — Headless Screws x Bouquet in Boxer's Fracture · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05050981 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Faculdade de Medicina do ABC
- Last refreshed: 10 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05050981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing